Interferon-α in the idiopathic hypereosinophilic syndrome: Consideration of five cases

Annals of Hematology

Volumn 77, Issue 4, 1998, Pages 161-164

  Ceretelli, S ^a   Capochiani, E ^a   Petrini, M ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Idiopathic hypereosinophilic syndrome (HES); Interferon (IFN) a; Therapy

Indexed keywords

ALPHA INTERFERON;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; MALE; PRIORITY JOURNAL; TISSUE INJURY;

ADULT; HUMANS; HYPEREOSINOPHILIC SYNDROME; INTERFERON-ALPHA; MALE; MIDDLE AGED; SEX CHROMOSOME ABERRATIONS; Y CHROMOSOME;

EID: 0031768159     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050434     Document Type: Article

References (15)

1. Owen WF, Rothenberg ME, Petersen J, Weller PF, Silberstein D, Sheffer AL, Stevens RL, Soberman RJ, Austen KF (1989) Interleukin-5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome. J Exp Med 170:343-8
2. Prin L, Plumas J, Gruart V, Loiseau S, Aldebert D, Ameisen JC, et al. (1991) Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 78:2626-32
3. Quiquandon I, Claisse JE, Capiod JC, Delobel J, Prin L (1995) Alpha interferon and hypereosinophilic syndrome with trisomy 8 karyotipic remission. Blood 85:2284-85
4. Schandene L, Del Prete GE, Cogan E, Stordeur P, Crusiaux A, Kennes B, Romagnani S, Goldman M. (1996) Recombinant interferon alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Investigation 97:309-15
5. Scherezenmeier H, Thomè SD, Tewald F, Fleischer B, Raghavachar A (1993) Interleukin-5 is the predominant eosinophilopoietin produced by cloned T-lymphocytes in hypereosinophilic syndrome. Exp Haematol 21:358-65
6. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Byornson BH (1982) The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic and therapeutic consideration. Ann Intern Med 97:78-92
7. Demiroglu H, Dunar S (1997) Combination of interferon alpha and hydroxyurea in the treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 97:927-40
8. Garcia-Isidoro M, Tabernero MD, Najera ML, Garcia JL, Hernandez JM, Duran A, San Miguel JF, Orafo A (1997) Clinical and biological characteristics of myelodisplastic syndromes with nullisomy Y by FISH. Haematologica 82:537-41
9. Heim S., Mitelman F (1995). Chromosomal and molecular genetic aberrations of tumor cell. Cancer genetics, 2nd ed. Wiley-Liss, New York
10. Butterfield JH, Glech GJ (1994). Interferon alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Int Med 121:648-53
11. Malbrain MLNG, Van den Berghe H, Zacchèe P (1996) Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon alpha in a case with a unique chromosomal abnormality. Br J Haematol 92:176-83
12. Schooley RT, Flaum MA, Gralnick HR, Fauci AS (1981) A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. II clinical manifestations. Blood 58:1021-6
13. Broxmeyer HE, Lu L, Platzer E, Feit C, Juliano L, Rubin BY (1983) Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131:1300-5
14. Van Den Anker- Lugtenburg PJ, Van't Veer MB (1991) Alpha interferon in a case of hypereosinophilic syndrome. Br J Haematol 77:258
15. Matutes E, Meeus P, McLennan K, Catovsky D (1997) The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long-term follow-up study. Br J Haematol 98:375-83